- Home
- |
- About
- |
- CIPA Safe Pharmacies
- |
- Verify a Website
- |
- FAQ's
- |
- News
- |
- Pharmacists Corner
- |
- Contact
Should I take Ivermectin for COVID-19 virus?
Ivermectin has not been proven to be useful in the prevention or treatment of COVID-19. It is used to treat intestinal parasites in the human body or head lice - not viruses.
Neither Health Canada nor the U.S. FDA have approved ivermectin for COVID-19 and both have issued warnings that even the levels that are approved for human uses can interact with other medications, like blood-thinners. Plus, you can also overdose on ivermectin, which can cause vomiting, diarrhea, low blood pressure, allergic reactions, dizziness, seizures, coma and even death.
According to the World Health Organization, COVID-19 is the infectious disease that was first identified following a viral outbreak that began in Wuhan, China, in December 2019. COVID-19 is a Coronavirus, a large family of viruses which may cause illness in animals or humans. In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS).
COVID-19 is most commonly spread from an infected person
Is there any risk of contracting COVID-19 from packages sent to me?
Official sources in North America agree that spread of the virus is likely very low risk from products or packaging that are shipped over a period of days or weeks at ambient (normal) temperatures. Coronaviruses are generally thought to be spread most often by respiratory droplets. According to the U.S. CDC, there is currently no evidence to support transmission of COVID-19 associated with imported goods and there have not been any cases of COVID-19 in the U.S. associated with imported goods. Learn more from the United States Centers for Disease Control and Prevention and the Public Health Agency of Canada.
Are there things I can do to keep myself safe?
According to the Canadian Pharmacists Association:
Should I buy a face mask to protect me from contracting COVID-19?
The Canadian Pharmacists Association has stated:
CIPA is a Canadian association of licensed, retail pharmacies. We sell safe and affordable prescription drugs made by the leading name-brand manufacturers at prices up to 80 percent less than U.S. pharmacies. CIPA member pharmacies have served more than 10 million patients since the organization's founding in 2002, with a 100% perfect safety record. This makes CIPA an immediate and credible part of the solution to exorbitantly high drug prices in the U.S.
Are all medications shipped from Canada?
CIPA members sell Health Canada-approved medications from their licensed pharmacies in Canada. In addition, CIPA members have relationships with regulated international pharmacies and inspected fulfillment centers based in other parts of the world that sell and directly deliver medications to patients from where they are located. Patients make the choice from where their medications will be delivered, and this is confirmed with them at time of purchase.
Can I trust any website that identifies itself as Canadian?
Beware of "rogue" websites that have a Canadian name, and possibly even claim to be a CIPA member, without displaying our official CIPA seal or using our seal in an unauthorized manner. These rogue sites may sell substandard and falsified medications made or distributed under unregulated and potentially unsafe methods, or controlled substances such as narcotics. Additionally, they may not require a valid prescription from your doctor, and some have been known to steal personal and payment information.
Customers should always verify that a website is a current CIPA member, following our association's strict policies and procedures designed to rigorously protect your privacy and your safety. Please visit the CIPA Safe Pharmacies page before placing your order, to verify a website - even one that does display the CIPA seal or might have previously been a member - is a current CIPA member pharmacy fully committed to your safety and satisfaction with your daily medications.
Should I buy from a website that is not CIPA certified?
CIPA certification assures you that the pharmacy provider is licensed, reputable and adheres to stringent safety protocols. CIPA member pharmacies:
Additionally, CIPA members do not send any unsolicited email (SPAM) or sell addresses to others. For your safety and privacy, we recommend dealing only with sites displaying the CIPA seal.
How can I make sure a website is CIPA certified?
CIPA certified websites display the CIPA seal as displayed below. Since this seal has become so respected for trustworthiness and integrity, some websites have copied the seal and placed it on their sites. These sites are masquerading as CIPA members but they are not. Always cross-check the CIPA.com website to ensure that a site selling medications is truly a CIPA member. To verify a member, click here.
Does the CIPA office sell medications?
CIPA is an association of pharmacies, and is not a pharmacy or wholesaler itself. The CIPA office does not stock, supply or distribute any pharmaceutical products. This is done by individual CIPA member pharmacies which are listed on our website.
Please contact a member pharmacy displaying the CIPA seal and that is verified at our website to answer any questions and have your prescription filled.
How can I find out how much it will cost to order my medication from a CIPA member?
Please visit any of the CIPA member websites on our Certified Safe Online Pharmacies list. Each one has a search tool to allow you to type in the name of your medication and see what options you have for ordering.
I want to avoid going to the doctor to get a prescription. Can I order from a CIPA member?
CIPA member pharmacies require a valid prescription from your physician for any medications that are sold as a prescription drug where you live.
CIPA members sell Health-Canada approved medications from their pharmacies in Canada, and have relationships with licensed international pharmacies to offer the same safety and even greater savings. Most countries outside of the U.S. have mechanisms in place to ensure that drugs are not priced excessively. In Canada, it's the Patented Medicine Prices Review Board (PMPRB).
How can I trust that CIPA member pharmacies are what they say they are?
CIPA Members must meet strict Standards of Practice to qualify for membership. Once becoming a member, CIPA members are monitored and their facilities inspected to ensure ongoing compliance with all Standards and policies.
All CIPA members adhere to the strict safety and privacy standards established by the Association. As a result, you will receive the same quality of product and professionalism regardless of which CIPA member website you choose.
While CIPA members pay a fee for the right to carry the CIPA Seal, not all online pharmacies qualify for membership, nor would all online pharmacies choose to adhere to the strict standards required of CIPA members. CIPA members are subject to ongoing monitoring and inspection of their practices and dispensing facilities and are subject to disciplinary action should they not comply with all practices and policies. Learn more about avoiding rogue websites here.
What do I do if I have a complaint about a CIPA member?
The CIPA office represents the interests and reputation of the Association, and this includes making sure that each patient receives excellent service from its CIPA member pharmacy. As a result, if there is ever a concern about your experience with one of our members, we urge you to contact us.
Are there new U.S. Customs importation requirements coming October 22, 2026?
Yes. U.S. Customs and Border Protection (CBP) is implementing new procedures that will end decades-long, case-by-case acceptance that has permitted importation of prescription medications for personal use from licensed pharmacies outside the U.S.
The Canadian International Pharmacy Association (CIPA) has ben informed directly by Zonos to discuss the new requirements and confirm its position.
At present, Zonos is the customs broker of record for nearly every major international mail system in the world. For most of those systems, it is currently the only customs broker they are working with in that capacity. Its ability to process prescription shipments therefore directly affects whether those parcels can enter the United States.
As communicated to CIPA, the requirements described below were dictated to Zonos by U.S. Customs and Border Protection (CBP) and will be enforced beginning October 22. They are not an independent operational or commercial decision by Zonos.
Zonos confirmed that, beginning October 22, it will not act as importer of record for pharmaceutical shipments where either:
These circumstances encompass virtually all routine prescription orders placed by American patients with licensed Canadian and international pharmacy services.
There is also public supporting information. Zonos's published guidance states: "If effective treatment is already available in the US, the exemption does not apply." It also explains that additional patient paperwork does not overcome the issue of a pharmacy marketing to U.S. residents. The broader supply-chain position described above was confirmed directly in CIPA's meeting with Zonos.
The post correctly identifies an October 22, 2026 compliance date in the official CBP rule. But recognizing that the rule changes customs-entry procedures does not establish that ordinary prescription parcels will continue to clear under those procedures.
The alternative Entry Type 13 process requires a qualified importer of record, a customs bond, electronic filings, and the applicable regulatory information. It does not waive the underlying requirements governing whether a medication may enter. Those obligations are documented in CBP's Entry Type 13 notice.
Changing an entry type therefore does not resolve the problem. Nor does pointing to the continued existence of discretionary personal-importation criteria establish that routine pharmacy orders will satisfy those criteria or that a broker can process them under the requirements communicated by CBP.
The distinction between a newly worded blanket prohibition and the practical closure of a shipping pathway matters when describing the law. But patients still need to know whether their medication will reach them. Our warning addresses that practical outcome, based on both the published requirements and direct confirmation of their planned implementation.
Based on that information, we expect the planned implementation to prevent virtually all routine personal-use prescription shipments from licensed Canadian and international pharmacies from reaching American patients beginning October 22, unless the policy or its implementation changes.
These warnings have received careful scrutiny. NorthWestPharmacy.com, a CIPA-certified member, has had its position carefully reviewed by attorneys, subject matter experts, and its executive team.
CPPI, an independent U.S. nonprofit patient-advocacy organization, is also publicly warning about this development. CIPA and CPPI openly advocate for continued access to affordable medication. That advocacy does not invalidate the underlying information. Multiple providers warning about the same problem is consistent with a shared threat to their ability to serve patients.
This is not fear-mongering. We have a duty to inform people while they still have time to make arrangements. Waiting until shipments can no longer reach patients would fail those who depend on them.
For members of this group, please speak promptly with your veterinarian and dispensing pharmacy about your cat's medication supply, appropriate refill quantities, storage, and expiration dates. Ask your pharmacy specifically how it expects your prescription shipment to be processed and cleared after October 22.
We welcome questions and scrutiny. Please consider the direct implementation information alongside the published rules before treating an AI-generated answer as reassurance that access will continue. You should also support efforts to preserve that access through CPPI's advocacy campaign.